Search

Your search keyword '"Loretz, Lucca"' showing total 23 results
Start Over Author "Loretz, Lucca"
23 results on '"Loretz, Lucca"'

4. Vascular Access in Patients With Peripheral Arterial Disease Undergoing TAVR: The Hostile Registry

Author

Palmerini, Tullio, Saia, Francesco, Kim, Won-Keun, Renker, Matthias, Iadanza, Alessandro, Fineschi, Massimo, Bruno, Antonio Giulio, Ghetti, Gabriele, Vanhaverbeke, Maarten, Søndergaard, Lars, De Backer, Ole, Romagnoli, Enrico, Burzotta, Francesco, Trani, Carlo, Adrichem, Rik, Van Mieghem, Nicolas M., Nardi, Elena, Chietera, Francesco, Orzalkiewicz, Mateusz, Tomii, Daijiro, Pilgrim, Thomas, Aranzulla, Tiziana Claudia, Musumeci, Giuseppe, Adam, Matti, Meertens, Max M., Taglieri, Nevio, Marrozzini, Cinzia, Alvarez Covarrubias, Hector Alfonso, Joner, Michael, Nardi, Giulia, Di Muro, Francesca Maria, Di Mario, Carlo, Loretz, Lucca, Toggweiler, Stefan, Gallitto, Enrico, Gargiulo, Mauro, Testa, Luca, Bedogni, Francesco, Berti, Sergio, Ancona, Marco B., Montorfano, Matteo, Leone, Alessandro, Savini, Carlo, Pacini, Davide, Gmeiner, Jonas, Braun, Daniel, Nerla, Roberto, Castriota, Fausto, De Carlo, Marco, Petronio, Anna Sonia, Barbanti, Marco, Costa, Giuliano, Tamburino, Corrado, Leone, Pier Pasquale, Reimers, Bernhard, Stefanini, Giulio, Sudo, Mitsumasa, Nickenig, Georg, Piva, Tommaso, Scotti, Andrea, Latib, Azeem, Vercellino, Matteo, Porto, Italo, Codner, Pablo, Kornowski, Ran, Bartorelli, Antonio L., Tarantini, Giuseppe, Fraccaro, Chiara, Abdel-Wahab, Mohamed, Grube, Eberhard, Galié, Nazzareno, and Stone, Gregg W.

Published
2023
Full Text
View/download PDF

12. Vascular Access in Patients With Peripheral Arterial Disease Undergoing TAVR:The Hostile Registry

Author

Palmerini, Tullio, Saia, Francesco, Kim, Won Keun, Renker, Matthias, Iadanza, Alessandro, Fineschi, Massimo, Bruno, Antonio Giulio, Ghetti, Gabriele, Vanhaverbeke, Maarten, Søndergaard, Lars, De Backer, Ole, Romagnoli, Enrico, Burzotta, Francesco, Trani, Carlo, Adrichem, Rik, Van Mieghem, Nicolas M., Nardi, Elena, Chietera, Francesco, Orzalkiewicz, Mateusz, Tomii, Daijiro, Pilgrim, Thomas, Aranzulla, Tiziana Claudia, Musumeci, Giuseppe, Adam, Matti, Meertens, Max M., Taglieri, Nevio, Marrozzini, Cinzia, Alvarez Covarrubias, Hector Alfonso, Joner, Michael, Nardi, Giulia, Di Muro, Francesca Maria, Di Mario, Carlo, Loretz, Lucca, Toggweiler, Stefan, Gallitto, Enrico, Gargiulo, Mauro, Testa, Luca, Bedogni, Francesco, Berti, Sergio, Ancona, Marco B., Montorfano, Matteo, Leone, Alessandro, Savini, Carlo, Pacini, Davide, Gmeiner, Jonas, Braun, Daniel, Nerla, Roberto, Castriota, Fausto, De Carlo, Marco, Petronio, Anna Sonia, Barbanti, Marco, Costa, Giuliano, Tamburino, Corrado, Leone, Pier Pasquale, Reimers, Bernhard, Stefanini, Giulio, Sudo, Mitsumasa, Nickenig, Georg, Piva, Tommaso, Scotti, Andrea, Latib, Azeem, Vercellino, Matteo, Porto, Italo, Codner, Pablo, Kornowski, Ran, Bartorelli, Antonio L., Tarantini, Giuseppe, Fraccaro, Chiara, Abdel-Wahab, Mohamed, Grube, Eberhard, Galié, Nazzareno, Stone, Gregg W., Palmerini, Tullio, Saia, Francesco, Kim, Won Keun, Renker, Matthias, Iadanza, Alessandro, Fineschi, Massimo, Bruno, Antonio Giulio, Ghetti, Gabriele, Vanhaverbeke, Maarten, Søndergaard, Lars, De Backer, Ole, Romagnoli, Enrico, Burzotta, Francesco, Trani, Carlo, Adrichem, Rik, Van Mieghem, Nicolas M., Nardi, Elena, Chietera, Francesco, Orzalkiewicz, Mateusz, Tomii, Daijiro, Pilgrim, Thomas, Aranzulla, Tiziana Claudia, Musumeci, Giuseppe, Adam, Matti, Meertens, Max M., Taglieri, Nevio, Marrozzini, Cinzia, Alvarez Covarrubias, Hector Alfonso, Joner, Michael, Nardi, Giulia, Di Muro, Francesca Maria, Di Mario, Carlo, Loretz, Lucca, Toggweiler, Stefan, Gallitto, Enrico, Gargiulo, Mauro, Testa, Luca, Bedogni, Francesco, Berti, Sergio, Ancona, Marco B., Montorfano, Matteo, Leone, Alessandro, Savini, Carlo, Pacini, Davide, Gmeiner, Jonas, Braun, Daniel, Nerla, Roberto, Castriota, Fausto, De Carlo, Marco, Petronio, Anna Sonia, Barbanti, Marco, Costa, Giuliano, Tamburino, Corrado, Leone, Pier Pasquale, Reimers, Bernhard, Stefanini, Giulio, Sudo, Mitsumasa, Nickenig, Georg, Piva, Tommaso, Scotti, Andrea, Latib, Azeem, Vercellino, Matteo, Porto, Italo, Codner, Pablo, Kornowski, Ran, Bartorelli, Antonio L., Tarantini, Giuseppe, Fraccaro, Chiara, Abdel-Wahab, Mohamed, Grube, Eberhard, Galié, Nazzareno, and Stone, Gregg W.

Abstract

Background: The optimal access route in patients with severe peripheral artery disease (PAD) undergoing transcatheter aortic valve replacement (TAVR) remains undetermined. Objectives: This study sought to compare clinical outcomes with transfemoral access (TFA), transthoracic access (TTA), and nonthoracic transalternative access (TAA) in TAVR patients with severe PAD. Methods: Patients with PAD and hostile femoral access (TFA impossible, or possible only after percutaneous treatment) undergoing TAVR at 28 international centers were included in this registry. The primary endpoint was the propensity-adjusted risk of 30-day major adverse events (MAE) defined as the composite of all-cause mortality, stroke/transient ischemic attack (TIA), or main access site–related Valve Academic Research Consortium 3 major vascular complications. Outcomes were also stratified according to the severity of PAD using a novel risk score (Hostile score). Results: Among the 1,707 patients included in the registry, 518 (30.3%) underwent TAVR with TFA after percutaneous treatment, 642 (37.6%) with TTA, and 547 (32.0%) with TAA (mostly transaxillary). Compared with TTA, both TFA (adjusted HR: 0.58; 95% CI: 0.45-0.75) and TAA (adjusted HR: 0.60; 95% CI: 0.47-0.78) were associated with lower 30-day rates of MAE, driven by fewer access site–related complications. Composite risks at 1 year were also lower with TFA and TAA compared with TTA. TFA compared with TAA was associated with lower 1-year risk of stroke/TIA (adjusted HR: 0.49; 95% CI: 0.24-0.98), a finding confined to patients with low Hostile scores (Pinteraction = 0.049). Conclusions: Among patients with PAD undergoing TAVR, both TFA and TAA were associated with lower 30-day and 1-year rates of MAE compared with TTA, but 1-year stroke/TIA rates were higher with TAA compared with TFA.

Published
2023

15. Clinical Outcomes and Prognosis Markers of Patients With Liver Disease Undergoing Transcatheter Aortic Valve Replacement: A Propensity Score–Matched Analysis

Author

Tirado-Conte, Gabriela, Rodés-Cabau, Josep, Rodríguez-Olivares, Ramón, Barbanti, Marco, Lhermusier, Thibault, Amat-Santos, Ignacio, Toggweiler, Stefan, Cheema, Asim N., Muñoz-García, Antonio J., Serra, Vicenc, Giordana, Francesca, Veiga, Gabriela, Jiménez-Quevedo, Pilar, Campelo-Parada, Francisco, Loretz, Lucca, Todaro, Denise, del Trigo, María, Hernández-García, José M., García del Blanco, Bruno, Bruno, Francesco, de la Torre Hernández, José M., Stella, Pieter, Tamburino, Corrado, Macaya, Carlos, and Nombela-Franco, Luis

Published
2018
Full Text
View/download PDF

18. Association of comorbid burden with clinical outcomes after transcatheter aortic valve implantation

Author

Bagur, Rodrigo, primary, Martin, Glen Philip, additional, Nombela-Franco, Luis, additional, Doshi, Sagar N, additional, George, Sudhakar, additional, Toggweiler, Stefan, additional, Sponga, Sandro, additional, Cotton, James M, additional, Khogali, Saib S, additional, Ratib, Karim, additional, Kinnaird, Tim, additional, Anderson, Richard A, additional, Chu, Michael W A, additional, Kiaii, Bob, additional, Biagioni, Corina, additional, Schofield-Kelly, Lois, additional, Loretz, Lucca, additional, Torracchi, Leonardo, additional, Sekar, Baskar, additional, Kwok, Chun Shing, additional, Sperrin, Matthew, additional, Ludman, Peter F, additional, and Mamas, Mamas A, additional

Published
2018
Full Text
View/download PDF

19. Clinical Outcomes and Prognosis Markers of Patients With Liver Disease Undergoing Transcatheter Aortic Valve Replacement A Propensity Score-Matched Analysis : A Propensity Score-Matched Analysis

Author

Tirado-Conte, Gabriela, Rodés-Cabau, Josep, Rodríguez-Olivares, Ramón, Barbanti, Marco, Lhermusier, Thibault, Amat-Santos, Ignacio, Toggweiler, Stefan, Cheema, Asim N., Muñoz-García, Antonio J., Serra, Vicenc, Giordana, Francesca, Veiga, Gabriela, Jiménez-Quevedo, Pilar, Campelo-Parada, Francisco, Loretz, Lucca, Todaro, Denise, Del Trigo, María, Hernández-García, José M., Del Blanco, Bruno García, Bruno, Francesco, De La Torre Hernández, José M., Stella, Pieter, Tamburino, Corrado, Macaya, Carlos, Nombela-Franco, Luis, Tirado-Conte, Gabriela, Rodés-Cabau, Josep, Rodríguez-Olivares, Ramón, Barbanti, Marco, Lhermusier, Thibault, Amat-Santos, Ignacio, Toggweiler, Stefan, Cheema, Asim N., Muñoz-García, Antonio J., Serra, Vicenc, Giordana, Francesca, Veiga, Gabriela, Jiménez-Quevedo, Pilar, Campelo-Parada, Francisco, Loretz, Lucca, Todaro, Denise, Del Trigo, María, Hernández-García, José M., Del Blanco, Bruno García, Bruno, Francesco, De La Torre Hernández, José M., Stella, Pieter, Tamburino, Corrado, Macaya, Carlos, and Nombela-Franco, Luis

Published
2018

20. Clinical Outcomes and Prognosis Markers of Patients With Liver Disease Undergoing Transcatheter Aortic Valve Replacement A Propensity Score-Matched Analysis: A Propensity Score-Matched Analysis

Author

Researchbureau DHL, Circulatory Health, Tirado-Conte, Gabriela, Rodés-Cabau, Josep, Rodríguez-Olivares, Ramón, Barbanti, Marco, Lhermusier, Thibault, Amat-Santos, Ignacio, Toggweiler, Stefan, Cheema, Asim N., Muñoz-García, Antonio J., Serra, Vicenc, Giordana, Francesca, Veiga, Gabriela, Jiménez-Quevedo, Pilar, Campelo-Parada, Francisco, Loretz, Lucca, Todaro, Denise, Del Trigo, María, Hernández-García, José M., Del Blanco, Bruno García, Bruno, Francesco, De La Torre Hernández, José M., Stella, Pieter, Tamburino, Corrado, Macaya, Carlos, Nombela-Franco, Luis, Researchbureau DHL, Circulatory Health, Tirado-Conte, Gabriela, Rodés-Cabau, Josep, Rodríguez-Olivares, Ramón, Barbanti, Marco, Lhermusier, Thibault, Amat-Santos, Ignacio, Toggweiler, Stefan, Cheema, Asim N., Muñoz-García, Antonio J., Serra, Vicenc, Giordana, Francesca, Veiga, Gabriela, Jiménez-Quevedo, Pilar, Campelo-Parada, Francisco, Loretz, Lucca, Todaro, Denise, Del Trigo, María, Hernández-García, José M., Del Blanco, Bruno García, Bruno, Francesco, De La Torre Hernández, José M., Stella, Pieter, Tamburino, Corrado, Macaya, Carlos, and Nombela-Franco, Luis

Published
2018

21. TCT-183 Clinical Outcomes and Prognosis Markers of Patients With Liver Disease Undergoing Transcatheter Aortic Valve Replacement: A Propensity Score-matched Analysis

Author

Nombela-Franco, Luis, primary, Tirado-Conte, Gabriela, additional, Rodés-Cabau, Josep, additional, Rodríguez-Olivares, Ramon, additional, Barbanti, Marco, additional, Lhermusier, Thibault, additional, Amat-Santos, Ignacio, additional, Toggweiler, Stefan, additional, Cheema, Asim, additional, Munoz-Garcia, Antonio, additional, Serra, Vicente, additional, Giordana, Francesca, additional, Veiga, Gabriela, additional, Quevedo, Pilar Jimenez, additional, Campelo-Parada, Francisco, additional, Loretz, Lucca, additional, Del Trigo, Maria, additional, Hernandez, Jose Maria, additional, Stella, Pieter, additional, Tamburino, Corrado, additional, and Macaya, Carlos, additional

Published
2017
Full Text
View/download PDF

23. Amplatzer or Figulla Flex II Occluder: a comparative study of outcomes after transcatheter patent foramen ovale closure.

Author

Toggweiler S, Moccetti F, Conrad N, Loretz L, Madanchi M, Bossard M, Attiger-Toller A, Cuculi F, and Wolfrum M

Subjects
Humans, Female, Adult, Middle Aged, Male, Treatment Outcome, Echocardiography, Cardiac Catheterization methods, Foramen Ovale, Patent diagnosis, Foramen Ovale, Patent surgery, Foramen Ovale, Patent complications, Stroke epidemiology, Stroke etiology, Stroke prevention & control, Septal Occluder Device adverse effects, Thromboembolism etiology
Abstract

Objectives: Percutaneous closure of a patent foramen ovale (PFO) for the prevention of recurrent paradoxical thromboembolic events has been shown to be safe and effective in randomized controlled trials. However, it remains uncertain if differences in the structure and design of the occluder devices impact the outcomes. The aim of this study was to compare results of percutaneous PFO closure using 2 widely used double-disc occluders., Methods: Consecutive patients who underwent percutaneous PFO closure with the Abbott Amplatzer occluder (APO) or the Occlutech Figulla-Flex-II occluder (OPO) at the Heart Center Lucerne between February 2017 and December 2022 were included in a registry. The primary endpoint was effective closure of the PFO, defined as a residual shunt grade 0 or 1, assessed by contrast echocardiogram at 6-month follow-up. Secondary endpoints included procedural efficacy/safety and major adverse cardiovascular events during the hospital stay and at 6-month follow-up., Results: One hundred ninety-three consecutive patients (mean age 51.7 ± 12.5 years; 39% women; Risk of Paradoxical Embolism (RoPE) score = 7, IQR = 6-8) underwent percutaneous PFO closure with the APO (120 patients, 62.2%) or the OPO (73 patients, 37.8%). Main indications for closure were crypotogenic stroke in 168 patients (87.1%) and peripheral embolism in 13 patients (6.7%). At baseline, right-to-left shunt (RLS) greater than or equal to grade 2 was present in 189 patients (97.9%). Immediate procedural success was 99.5%. In 1 patient, an air embolism occurred during positioning of the APO occluder with transient chest pain and electrocardiogram changes, but without further sequelae to the patient. At 6-month follow-up, effective closure was achieved in 185 patients (95.8%; APO: 96.6% vs OPO: 94.5%, P = .30). Rates of atrial fibrillation and recurrent thromboembolic events were 4.2 and 0.5%, respectively., Conclusions: PFO closure is safe and effective when performed with either the self-expanding Abbott Amplatzer or Occlutech Figulla Flex II PFO occluder.

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results